Zacks Investment Research upgraded shares of Eurofins Scientifi (NASDAQ:ERFSF) from a hold rating to a buy rating in a research note published on Monday, September 11th. Zacks Investment Research currently has $645.00 price target on the stock.
According to Zacks, “Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. “
Shares of Eurofins Scientifi (NASDAQ ERFSF) remained flat at $599.20 during trading on Monday. The firm’s 50 day moving average is $570.40 and its 200 day moving average is $521.94. Eurofins Scientifi has a 52-week low of $413.57 and a 52-week high of $603.20. The firm has a market capitalization of $10.19 billion and a price-to-earnings ratio of 58.34.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Eurofins Scientifi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scientifi and related companies with our FREE daily email newsletter.